Biosyntia
Our uniqueness is our technology
Denmark
23 employees
Series B
Total: $17.37M
Biopharma, Biotechnology +1
General Information
Get notified when Biosyntia moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Biosyntia
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Denmark Market
Biopharma
About Biosyntia
Taxonomy: biotech, synthetic biology, metabolic engineering, biocatalysts, high-throughput screening technology, tailored processes, fermentation, fine chemical compounds, sustainable manufacturing processes, green technology, startup incubator, Copenhagen, chemical synthesis
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 3 |
|
06 Jul 2022 |
| Series A | •••••• | 2 |
|
23 May 2018 |
| Seed Round | •••••• | 2 |
|
21 May 2015 |
Biosyntia Alternatives & Competitors
Our experience is the guarantee. Our success is the proof. Our commitment is the future.
Offering innovative software tools for the chemical mixing industry.
Oxford Biotrans is a University of Oxford spin-out company supported by over 15 years of research by...
FAQ About Biosyntia
Don't just browse. Track.
Signal Tracker monitors Biosyntia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.